McKenzie Griffin is a junior at Boston University pursuing a B.S. in Health Science. She has previously worked in the Bryant Lab at Boston University School of Medicine on a study investigating the genetic factors that dictate differing behavioral responses of opioid use. While abroad in countries such as Peru and Greece, McKenzie worked as a clinical intern specializing in patients with neurological disorders and hematologic diseases. At MGH, McKenzie assists on multiple studies including a study that asses transcranial magnetic stimulation as a treatment for OCD. After graduating, she plans to attend medical school.
